| Doctors Immedicare | |
|
1802 Harper Rd Ste 102 Beckley WV 25801 | |
| (304) 252-9211 | |
| (304) 252-9218 |
| Full Name | Doctors Immedicare |
|---|---|
| Speciality | Clinic/Center |
| Location | 1802 Harper Rd Ste 102, Beckley, West Virginia |
| Authorized Official Name and Position | Prakash Puranik (MEMBER) |
| Authorized Official Contact | 3042529211 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Doctors Immedicare 1802 Harper Rd Ste 102 Beckley WV 25801-3376 Ph: (304) 252-9211 | Doctors Immedicare 1802 Harper Rd Ste 102 Beckley WV 25801 Ph: (304) 252-9211 |
| NPI Number | 1932190865 |
|---|---|
| Provider Enumeration Date | 10/31/2005 |
| Last Update Date | 02/06/2020 |
| Medicare PECOS PAC ID | 1456256239 |
|---|---|
| Medicare Enrollment ID | O20031204000691 |
News Archive
Lithium is a common medication prescribed to patients with psychiatric disorders, namely bipolar disorder, schizophrenia, and depression.
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from Boehringer Ingelheim, one of the world's 20 leading pharmaceutical companies. Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic syndrome-related diseases in a strategic alliance with Boehringer Ingelheim. The payment recognizes Boehringer Ingelheim's recent advancement of a small molecule inhibitor of 11beta-HSD-1 into Phase I clinical trials.
Found in 30% of all human cancer tumors, the Ras protein literally "drives cells crazy," says Prof. Yoel Kloog, the dean of the Faculty of Life Sciences at Tel Aviv University. Prof. Kloog was the first in the world to develop an effective anti-Ras drug against pancreatic cancer, currently in clinical trials. Now, new research published in the June issue of the European Journal of Pharmacology shows that the drug might be able to slow the progression of diabetes as well.
Researchers at UCLA say it's not just what you eat that makes those pants tighter - it's also genetics. In a new study, scientists discovered that body-fat responses to a typical fast-food diet are determined in large part by genetic factors, and they have identified several genes they say may control those responses.
Muscle strength in adolescence is significantly associated with the likelihood for early death, reveal results from a large study of Swedish teenagers.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932190865 | NPI | - | NPPES |
| 970026849 | Other | WV | RR MCARE |
| 51D0235325 | Other | WV | CLIA |
| 75159 | Other | WV | CARELINK |
| 001707274 | Other | WV | BC |
| 28130 | Other | WV | COLA |
| 001894000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
| 261QM1300X | Clinic/center - Multi-specialty | (* (Not Available)) | Primary |
| Provider Name | Prakash Puranik |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1538270590 PECOS PAC ID: 4385544683 Enrollment ID: I20040114000331 |
News Archive
Lithium is a common medication prescribed to patients with psychiatric disorders, namely bipolar disorder, schizophrenia, and depression.
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from Boehringer Ingelheim, one of the world's 20 leading pharmaceutical companies. Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic syndrome-related diseases in a strategic alliance with Boehringer Ingelheim. The payment recognizes Boehringer Ingelheim's recent advancement of a small molecule inhibitor of 11beta-HSD-1 into Phase I clinical trials.
Found in 30% of all human cancer tumors, the Ras protein literally "drives cells crazy," says Prof. Yoel Kloog, the dean of the Faculty of Life Sciences at Tel Aviv University. Prof. Kloog was the first in the world to develop an effective anti-Ras drug against pancreatic cancer, currently in clinical trials. Now, new research published in the June issue of the European Journal of Pharmacology shows that the drug might be able to slow the progression of diabetes as well.
Researchers at UCLA say it's not just what you eat that makes those pants tighter - it's also genetics. In a new study, scientists discovered that body-fat responses to a typical fast-food diet are determined in large part by genetic factors, and they have identified several genes they say may control those responses.
Muscle strength in adolescence is significantly associated with the likelihood for early death, reveal results from a large study of Swedish teenagers.
› Verified 8 days ago
| Provider Name | Deborah L Marra |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700877644 PECOS PAC ID: 4082650767 Enrollment ID: I20050705000115 |
News Archive
Lithium is a common medication prescribed to patients with psychiatric disorders, namely bipolar disorder, schizophrenia, and depression.
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from Boehringer Ingelheim, one of the world's 20 leading pharmaceutical companies. Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic syndrome-related diseases in a strategic alliance with Boehringer Ingelheim. The payment recognizes Boehringer Ingelheim's recent advancement of a small molecule inhibitor of 11beta-HSD-1 into Phase I clinical trials.
Found in 30% of all human cancer tumors, the Ras protein literally "drives cells crazy," says Prof. Yoel Kloog, the dean of the Faculty of Life Sciences at Tel Aviv University. Prof. Kloog was the first in the world to develop an effective anti-Ras drug against pancreatic cancer, currently in clinical trials. Now, new research published in the June issue of the European Journal of Pharmacology shows that the drug might be able to slow the progression of diabetes as well.
Researchers at UCLA say it's not just what you eat that makes those pants tighter - it's also genetics. In a new study, scientists discovered that body-fat responses to a typical fast-food diet are determined in large part by genetic factors, and they have identified several genes they say may control those responses.
Muscle strength in adolescence is significantly associated with the likelihood for early death, reveal results from a large study of Swedish teenagers.
› Verified 8 days ago
| Provider Name | Tara L Jackson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790028082 PECOS PAC ID: 5395972608 Enrollment ID: I20131212000343 |
News Archive
Lithium is a common medication prescribed to patients with psychiatric disorders, namely bipolar disorder, schizophrenia, and depression.
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from Boehringer Ingelheim, one of the world's 20 leading pharmaceutical companies. Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic syndrome-related diseases in a strategic alliance with Boehringer Ingelheim. The payment recognizes Boehringer Ingelheim's recent advancement of a small molecule inhibitor of 11beta-HSD-1 into Phase I clinical trials.
Found in 30% of all human cancer tumors, the Ras protein literally "drives cells crazy," says Prof. Yoel Kloog, the dean of the Faculty of Life Sciences at Tel Aviv University. Prof. Kloog was the first in the world to develop an effective anti-Ras drug against pancreatic cancer, currently in clinical trials. Now, new research published in the June issue of the European Journal of Pharmacology shows that the drug might be able to slow the progression of diabetes as well.
Researchers at UCLA say it's not just what you eat that makes those pants tighter - it's also genetics. In a new study, scientists discovered that body-fat responses to a typical fast-food diet are determined in large part by genetic factors, and they have identified several genes they say may control those responses.
Muscle strength in adolescence is significantly associated with the likelihood for early death, reveal results from a large study of Swedish teenagers.
› Verified 8 days ago
| Provider Name | Melissa R Baker |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1063857126 PECOS PAC ID: 9931337649 Enrollment ID: I20131231001848 |
News Archive
Lithium is a common medication prescribed to patients with psychiatric disorders, namely bipolar disorder, schizophrenia, and depression.
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from Boehringer Ingelheim, one of the world's 20 leading pharmaceutical companies. Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic syndrome-related diseases in a strategic alliance with Boehringer Ingelheim. The payment recognizes Boehringer Ingelheim's recent advancement of a small molecule inhibitor of 11beta-HSD-1 into Phase I clinical trials.
Found in 30% of all human cancer tumors, the Ras protein literally "drives cells crazy," says Prof. Yoel Kloog, the dean of the Faculty of Life Sciences at Tel Aviv University. Prof. Kloog was the first in the world to develop an effective anti-Ras drug against pancreatic cancer, currently in clinical trials. Now, new research published in the June issue of the European Journal of Pharmacology shows that the drug might be able to slow the progression of diabetes as well.
Researchers at UCLA say it's not just what you eat that makes those pants tighter - it's also genetics. In a new study, scientists discovered that body-fat responses to a typical fast-food diet are determined in large part by genetic factors, and they have identified several genes they say may control those responses.
Muscle strength in adolescence is significantly associated with the likelihood for early death, reveal results from a large study of Swedish teenagers.
› Verified 8 days ago
| Provider Name | Kristen Sisler |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386289320 PECOS PAC ID: 2163841867 Enrollment ID: I20200930000374 |
News Archive
Lithium is a common medication prescribed to patients with psychiatric disorders, namely bipolar disorder, schizophrenia, and depression.
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from Boehringer Ingelheim, one of the world's 20 leading pharmaceutical companies. Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic syndrome-related diseases in a strategic alliance with Boehringer Ingelheim. The payment recognizes Boehringer Ingelheim's recent advancement of a small molecule inhibitor of 11beta-HSD-1 into Phase I clinical trials.
Found in 30% of all human cancer tumors, the Ras protein literally "drives cells crazy," says Prof. Yoel Kloog, the dean of the Faculty of Life Sciences at Tel Aviv University. Prof. Kloog was the first in the world to develop an effective anti-Ras drug against pancreatic cancer, currently in clinical trials. Now, new research published in the June issue of the European Journal of Pharmacology shows that the drug might be able to slow the progression of diabetes as well.
Researchers at UCLA say it's not just what you eat that makes those pants tighter - it's also genetics. In a new study, scientists discovered that body-fat responses to a typical fast-food diet are determined in large part by genetic factors, and they have identified several genes they say may control those responses.
Muscle strength in adolescence is significantly associated with the likelihood for early death, reveal results from a large study of Swedish teenagers.
› Verified 8 days ago
| Provider Name | Michael Allen Beswick |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1164776589 PECOS PAC ID: 6406265719 Enrollment ID: I20210517001570 |
News Archive
Lithium is a common medication prescribed to patients with psychiatric disorders, namely bipolar disorder, schizophrenia, and depression.
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from Boehringer Ingelheim, one of the world's 20 leading pharmaceutical companies. Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic syndrome-related diseases in a strategic alliance with Boehringer Ingelheim. The payment recognizes Boehringer Ingelheim's recent advancement of a small molecule inhibitor of 11beta-HSD-1 into Phase I clinical trials.
Found in 30% of all human cancer tumors, the Ras protein literally "drives cells crazy," says Prof. Yoel Kloog, the dean of the Faculty of Life Sciences at Tel Aviv University. Prof. Kloog was the first in the world to develop an effective anti-Ras drug against pancreatic cancer, currently in clinical trials. Now, new research published in the June issue of the European Journal of Pharmacology shows that the drug might be able to slow the progression of diabetes as well.
Researchers at UCLA say it's not just what you eat that makes those pants tighter - it's also genetics. In a new study, scientists discovered that body-fat responses to a typical fast-food diet are determined in large part by genetic factors, and they have identified several genes they say may control those responses.
Muscle strength in adolescence is significantly associated with the likelihood for early death, reveal results from a large study of Swedish teenagers.
› Verified 8 days ago
News Archive
Lithium is a common medication prescribed to patients with psychiatric disorders, namely bipolar disorder, schizophrenia, and depression.
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from Boehringer Ingelheim, one of the world's 20 leading pharmaceutical companies. Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic syndrome-related diseases in a strategic alliance with Boehringer Ingelheim. The payment recognizes Boehringer Ingelheim's recent advancement of a small molecule inhibitor of 11beta-HSD-1 into Phase I clinical trials.
Found in 30% of all human cancer tumors, the Ras protein literally "drives cells crazy," says Prof. Yoel Kloog, the dean of the Faculty of Life Sciences at Tel Aviv University. Prof. Kloog was the first in the world to develop an effective anti-Ras drug against pancreatic cancer, currently in clinical trials. Now, new research published in the June issue of the European Journal of Pharmacology shows that the drug might be able to slow the progression of diabetes as well.
Researchers at UCLA say it's not just what you eat that makes those pants tighter - it's also genetics. In a new study, scientists discovered that body-fat responses to a typical fast-food diet are determined in large part by genetic factors, and they have identified several genes they say may control those responses.
Muscle strength in adolescence is significantly associated with the likelihood for early death, reveal results from a large study of Swedish teenagers.
› Verified 8 days ago
Family Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 25 Mallard Ct, Beckley, WV 25801 Phone: 304-929-6020 | |
Beckley-uha Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 410 Carriage Dr, Beckley, WV 25801 Phone: 304-255-1544 | |
Dtg Ii Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 110 Main St, Beckley, WV 25801 Phone: 800-268-7713 Fax: 415-704-3294 | |
Community Health Systems Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1129 S Fayette St, Beckley, WV 25801 Phone: 304-256-4604 | |
New River Health Association, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1804 Harper Rd Ste A, Beckley, WV 25801 Phone: 304-469-2905 | |
Gastroenterology Of Southern Wv Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1844 Harper Rd, Beckley, WV 25801 Phone: 304-250-0307 Fax: 304-250-0384 | |
Community Health Systems Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 202 Bill Barker Way, Beckley, WV 25801 Phone: 304-252-8324 |